team
health
profession
includ
clinician
virologist
epidemiologist
public
health
profession
environment
engin
studi
contain
diseas
intern
respons
enabl
rapid
identif
infecti
agent
mode
transmiss
develop
diagnost
test
tradit
public
health
measur
exampl
case
detect
isol
stringent
infect
control
contact
trace
surveil
use
global
success
break
chain
transmiss
sar
remain
public
health
challeng
sever
reason
includ
nonspecif
symptom
sign
lack
diagnost
test
use
reliabl
detect
sarscov
first
day
ill
risk
superspread
event
fuell
larg
diseas
cluster
outbreak
lack
vaccin
agre
treatment
modal
limit
data
ongo
risk
interspeci
transmiss
reemerg
sar
largescal
possibl
prepared
public
health
healthcar
system
import
prevent
control
diseas
new
knowledg
despit
rapid
progress
made
global
understand
sar
mani
question
remain
includ
risk
reemerg
sar
establish
sar
research
advisori
committe
review
evid
determin
gap
knowledg
make
recommend
public
health
research
prioriti
recommend
made
includ
elucid
chlamydia
afflict
million
peopl
annual
main
caus
prevent
childhood
blind
develop
countri
well
caus
infertil
worldwid
although
chlamydia
treatabl
antibiot
lack
februari
volum
wwwnaturecomreviewsmicro
h
g
h
l
g
h
obviou
symptom
complic
diagnosi
cheap
dipstick
test
call
firstburst
give
result
onthespot
less
minut
develop
bonu
featur
test
simplic
use
stabil
high
temperatur
wellcom
trust
giant
pouch
rat
tanzania
train
detect
tuberculosi
tb
snif
saliva
sampl
train
month
rat
correctli
identifi
sampl
contain
mycobacterium
tuberculosi
caus
agent
diseas
project
director
bart
weetjen
obtain
fund
train
team
sniffer
rat
rat
analys
sampl
minut
compar
sampl
per
day
train
scientist
tackl
live
could
save
earli
tb
detect
essenti
effect
treatment
scidevnet
major
hurdl
vaccin
mening
exist
multipl
strain
bacteria
known
group
b
c
caus
diseas
engin
meningococc
strain
provid
protect
mice
three
group
meningococc
bacteria
develop
mening
fatal
infect
children
unit
kingdom
mani
survivor
left
sever
handicap
vaccin
present
use
nt
protect
three
strain
breakthrough
could
first
step
toward
singl
vaccin
human
bbc
countri
probabl
sar
case
global
distribut
probabl
sar
case
countri
follow
two
incid
scientist
caught
sar
lab
latest
case
confirm
test
carri
whodesign
refer
lab
patient
chines
provinc
guangdong
although
nowrecov
patient
nt
link
known
sar
sourc
author
slaughter
civet
cat
test
gene
viru
infect
patient
show
similar
coronaviru
found
civet
transmiss
dynam
interspeci
transmiss
riskbenefit
analysi
therapeut
modal
use
outbreak
develop
protocol
futur
multicentr
clinic
trial
diagnost
qualiti
assur
laboratori
biosafeti
analysi
social
econom
impact
sar
public
health
measur
use
control
minimum
level
global
prepared
requir
reduc
risk
emerg
infecti
diseas
mitig
impact
also
discuss
sar
aetiolog
network
sequenc
sarscov
genom
develop
sever
diagnost
test
unpreced
speed
howev
avail
test
still
lack
suffici
sensit
earli
diseas
evalu
perform
differ
epidemiolog
situat
requir
research
also
progress
sar
vaccin
inactiv
live
attenu
subunit
vaccin
among
investig
first
clinic
trial
inactiv
sar
vaccin
expect
begin
earli
ref
new
strategi
polici
partnership
establish
global
surveil
suspect
probabl
sar
case
basi
clinic
epidemiolog
criteria
modifi
postoutbreak
period
reflect
need
ongo
vigil
low
nonzero
risk
sar
countri
incorpor
laboratori
case
definit
revis
also
made
intern
health
regul
provid
legal
framework
global
surveil
report
infecti
diseas
mechan
measur
prevent
intern
spread
enforc
sar
epidem
sever
stretch
nation
health
system
affect
countri
test
capac
goarn
partner
respond
quickli
effect
global
health
emerg
sar
shown
import
intern
collabor
deal
emerg
infecti
diseas
threat
invalu
posit
occupi
global
health
secur
privileg
access
member
state
abl
undertak
global
coordin
sar
respons
facilit
share
inform
health
profession
global
surveil
laboratori
research
team
mobil
technic
cooper
global
experi
gain
outbreak
increas
readi
implement
prevent
contain
control
measur
quickli
effect
sar
return
